Aptinyx Inc reported $24.29M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Biogen BIIB:US $ 7277.2M 2M
Cara Therapeutics CARA:US $ 0 0
Daiichi Sankyo 4568:JP Y 163367M 94M
Eli Lilly And LLY:US $ 16813.8M 305M
Halozyme Therapeutics HALO:US $ 1246.18M 368.53M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
Marinus Pharmaceuticals MRNS:US $ 70.35M 0.42M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 31031M 244M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M